Hepatitis C Virus (HCV)–Specific Immune Responses of Long-Term Injection Drug Users Frequently Exposed to HCV

BACKGROUND: Injection drug users (IDUs) who successfully clear hepatitis C virus (HCV) have a reduced risk of developing chronic reinfection, despite their continuing exposure to the virus. To identify immunological correlates for this apparent protection, we studied HCV-specific immune responses in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mizukoshi, Eishiro, Eisenbach, Christoph, Edlin, Brian R., Newton, Kimberly P., Raghuraman, Sukanya, Weiler-Normann, Christina, Tobler, Leslie H., Busch, Michael P., Carrington, Mary, McKeating, Jane A., O’Brien, Thomas R., Rehermann, Barbara
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699613/
https://ncbi.nlm.nih.gov/pubmed/18505381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/589510
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares